Immediate Dental Implants Connective Tissue Graft Esthetic Zone Clinical Trial
Official title:
Facial Gingival Level Evaluation Following Soft Tissue Augmentation Using Connective Tissue Graft Around Immediate Dental Implants Versus Immediate Dental Implants Alone in the Esthetic Zone. Randomized Controlled Trial.
| NCT number | NCT03334994 |
| Other study ID # | 302017 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | January 1, 2018 |
| Est. completion date | February 2, 2020 |
| Verified date | June 2020 |
| Source | Cairo University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Aim of current study to evaluate connective tissue graft combined with immediate implant placement as an innovative option for less facial gingival tissue recession, less pocket depth and less clinical attachment loss versus immediate implant alone.
| Status | Completed |
| Enrollment | 18 |
| Est. completion date | February 2, 2020 |
| Est. primary completion date | January 1, 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years to 55 Years |
| Eligibility |
Inclusion Criteria: 1. 18-55 2. Patients with single or multiple non-restorable teeth in maxillary anterior or premolar area. 3. Patients with adequate bone volume for the dental implant procedure. 4. Patients who are compliant to oral hygiene measures. 5. Patient consent approval and signing. Exclusion Criteria: 1. Heavy smokers. 2. Systemic disease that contraindicates implant placement or surgical procedures. 3. No or poor patient's compliance. 4. Psychological problems. 5. Pathology at the site of intervention. 6. Pregnancy females. |
| Country | Name | City | State |
|---|---|---|---|
| Egypt | Cairo University, Faculty of Dentistry. | Giza |
| Lead Sponsor | Collaborator |
|---|---|
| Cairo University |
Egypt,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Facial gingival level | FGL was evaluated by measuring the distance between the level of soft tissues and the lower border of the customized template that was used as a reference line at three readings mesially, mid-facially and distally. | Up to 6 months | |
| Secondary | Pain score | Visual analog scale was recorded every day for 12 days follow-up and the patient marks on the line the point they feel that it represents their response | Up to 12 days | |
| Secondary | Patient satisfaction | Post-Surgical Patient Satisfaction Questionnaire (PSPSQ). The patient questionnaire evaluates patients' perception and subjective admiration of the final result of the treatment | Up to 6 month | |
| Secondary | Tissue biotype | Thickness of the peri-implant mucosa around the implant | Up to 6 months | |
| Secondary | Pink esthetic score | seven different variables: mesial papilla, distal papilla, facial soft-tissue level, soft tissue contour, alveolar process deficiency, soft-tissue color and texture at the facial aspect of the implant site | Up to 6 months | |
| Secondary | Width of keratinized mucosa | distance from the mucogingival junction (MGJ) to the gingival margin | Up to 6 months | |
| Secondary | Bleeding on probing | Bleeding was provoked by sweeping the peri-implant mucosal sulcus using a periodontal probe. | Up to 6 months | |
| Secondary | Probing depth | distance from the peri- implant mucosal margin to the bottom of the peri-implant sulcus | Up to 6 months | |
| Secondary | Probing attachment level | distance from the base of the peri-implant sulcus to the implant shoulder using periodontal probe at four sites | Up to 6 months |